Skip to Content
  • Not Fun Reading

    These numbers from Deloitte are not very reassuring. They do an annual survey of spending and returns on investment in the drug industry, and this year’s… Read More
  • Out of Ideas?

    The Wall Street Journal came out with a series of articles on innovation in the US, and the biopharma industry features quite a bit in them. The lead one is an… Read More
  • If Design Govern in a Thing So Small

    It will not have escaped the notice of most readers of this site that biopharma stocks have been up strongly since the election. I don’t recall anyone pre… Read More
  • Productivity Over the Years

    The last couple of years have been very good for the number of drug approvals, reversing a rather worrying trend. But are these data points themselves enough to… Read More
  • Novartis Revamps

    Novartis has done a big reshuffle of its R&D structure, but what’s not clear is if it’s one of those reshuffles that ends up with fewer jobs th… Read More
  • Pfizer Says They Won’t Break Up

    Pfizer has been mulling over the idea of turning into at least two Pfizers for a long time now, but they’re out with an announcement this morning that th… Read More
Page 5 of 103« First...34567...102030...Last »